Sort
39,280 grants matching “leukemia”
4'-Substituted nucleoside analogs as anticancer drugs
$441,240John A Secrist · Southern Research Institute · R01 · FY2012 · CA
4'-Substituted nucleoside analogs as anticancer drugs
$441,240John A Secrist · Southern Research Institute · R01 · FY2011 · CA
Combinatorial Use of Anti-HIV RNA-based Therapeutics
$441,192John Joseph Rossi · Beckman Research Institute/City Of Hope · R01 · FY2011 · AI
Overcoming Therapy Resistance in Fusion Oncoprotein Driven Pediatric Leukemia
$441,178Elvin Wagenblast · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Overcoming Therapy Resistance in Fusion Oncoprotein Driven Pediatric Leukemia
$441,178Elvin Wagenblast · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Cancer in adults following in utero and early life exposure to arsenic
$441,149Craig M Steinmaus · University Of California Berkeley · R01 · FY2015 · ES
A Training Program in Molecular Hematology
$441,142Robert I Handin · Harvard Medical School · T32 · FY2010 · HL
Blocking cardiac toxicity of anticancer drugs
$441,129Mahesh P Gupta · University Of Chicago · R01 · FY2015 · HL
Project 1: Biomarkers of Chemical Exposure and Leukemia Risk
$441,111Patricia A Buffler · University Of California Berkeley · P42 · FY2010 · ES
Project 2: REG3A Regulation of GI GVHD
$441,044James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2020 · CA
Regulation of neutrophil function by ROS-induced actin glutathionylation
$441,042Hongbo R Luo · Boston Children'S Hospital · R01 · FY2015 · AI
The Role of DNMT3B in the DNA Methylation of Cancer Cells
$441,011Lucy Ann Godley · University Of Chicago · R01 · FY2011 · CA
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
$440,975Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Global Predictions and Tests of Erythroid Regulation
$440,906Ross C Hardison · Pennsylvania State University, The · R01 · FY2007 · DK
Delineating how retinoic acids regulate lipid metabolism in glioblastoma and their resistance mechanisms
$440,840Deliang Guo · Ohio State University · R01 · FY2021 · CA
Inflammation, Macrophage Differentiation, and Cancer
$440,815Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
CLINICAL TRIALS OF ALLOGENEIC STEM CELL TRANSPLANT IN LYMPHOHEMATOPOIETIC DISORDE
$440,614Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
Base-Edited Hematopoietic Stem and Progenitor Cells To Enable Safe Use Of Highly Potent CD33-Targeted Radioimmunotherapy
$440,557Roland Bruno Walter · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Aptamers for Imaging and Therapy
$440,517Richard T Hamilton · Aptalogic, Inc · R42 · FY2009 · CA
Project 3: Role of CTCF in HTLV-1 Replication and Transformation
$440,485Lee Ratner · Ohio State University · P01 · FY2023 · CA
ST Louis-Cape Girardeau CCOP
$440,482Bethany Sleckman · St. John'S Mercy Medical Center · U10 · FY2007 · CA
Personalized Risk-AdaptIve Surveillance (PRAISE) - Implications of Algorithmic Bias
$440,450Aasthaa Bansal · University Of Washington · R37 · FY2023 · CA
Validation of prognostic and pathway signatures in lethal prostate cancer
$440,421Susan Halabi · Duke University · U01 · FY2014 · CA
Defining the roles of RIPK1 and RIPK3 in emergency hematopoiesis
$440,417Ben Adam Croker · Boston Children'S Hospital · R01 · FY2015 · HL
Mechanisms of megakaryocyte maturation
$440,381Diane S. Krause · Yale University · R01 · FY2014 · DK